Skip Navigation



IJE Advance Access published online on June 25, 2009
International Journal of Epidemiology, doi:10.1093/ije/dyp233
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ma, Y.
Right arrow Articles by Chen, R. Y
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ma, Y.
Right arrow Articles by Chen, R. Y
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2009; all rights reserved.

Cohort Profile: The Chinese national free antiretroviral treatment cohort

Ye Ma1, Fujie Zhang1,2,*, Yan Zhao1, Chunpeng Zang1, Decai Zhao1, Zhihui Dou1, Lan Yu1, Hua Fang1, Timothy Y Zhu1 and Ray Y Chen3

1National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
2Beijing Ditan Hospital, Beijing, China.
3National Institute of Allergy and Infectious Diseases, National Institutes of Health, U.S. Embassy, Beijing, China.

*Corresponding author. National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, 27 Nanwei Road, Beijing 100050, China. E-mail: treatment@chinaaids.cn

Accepted 20 May 2009

The first 150 words of the full text of this article appear below.


   How did the study come about?
 
The human immunodeficiency virus (HIV) epidemic in China, with its unique but tragic cohort of former plasma donors (FPD) in central China, has been well reviewed.1–3 Overall, China does not have a big HIV problem, with only ~0.05% of the total population infected. With 1.3 billion people, however, this equates to an estimated 700 000 infected individuals, with high rates reported among the high-risk cohorts of FPD, injection drug users, female sex workers and men who have sex with men. Among the estimated 85 000 with acquired immunodeficiency syndrome (AIDS), 62 838 have been reported as of October 2007.4

In October 2002, the China Ministry of Health (MOH) directed the National Center for AIDS/STD Control and Prevention (NCAIDS) to initiate a pilot free HIV treatment programme in one county in Henan Province, the epicentre of the FPD epidemic. This pilot, called China Comprehensive AIDS Response (China CARES), was subsequently expanded . . . [Full Text of this Article]


   What does the study cover?
 

   Who is in the sample?
 

   How often are they being followed-up?
 

   What is attrition like?
 

   What has been found?
 

   What are the main strengths and weaknesses?
 

   Where can I find out more and what is the potential for collaboration?
 

   Funding
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
F. Zhang, Z. Dou, Y. Ma, Y. Zhao, Z. Liu, M. Bulterys, and R. Y. Chen
Five-Year Outcomes of the China National Free Antiretroviral Treatment Program
Ann Intern Med, August 18, 2009; 151(4): 241 - 251.
[Abstract] [Full Text] [PDF]